Partner Mike Okaty was quoted in an Orlando Business Journal article, “Winter Park biopharma firm Cytocom to go public through merger,” about a merger agreement between Winter Park-based Cytocom Inc. and Cleveland BioLabs Inc., two pharmaceutical companies focused on developing treatments that boost the body’s immune system.
Okaty said health care is an industry where opportunities for mergers and acquisitions persist despite the pandemic. While M&A activity dropped to nearly nothing during the early summer, it has slowly returned in August and September, he said, and is expected to continue growing through the remainder of 2020.
(Subscription required.)
Okaty said health care is an industry where opportunities for mergers and acquisitions persist despite the pandemic. While M&A activity dropped to nearly nothing during the early summer, it has slowly returned in August and September, he said, and is expected to continue growing through the remainder of 2020.
(Subscription required.)
People
Related News
July 24, 2025
In the News
Foley's Trial Team Featured Following Landmark Victory in Texas Trade Secret Case
Foley & Lardner LLP’s recent landmark appellate victory in a Texas trade secrets case is featured in the Texas Lawyer article, "Ruling Sets Precedent for Employment, Trade Secrets, Fiduciary Duty."
July 24, 2025
In the News
Gregory Husisian and David Simon on Tariff Evasion – 'Huge money at stake'
Foley & Lardner LLP partners Gregory Husisian and David Simon detailed the rise and risks of tariff evasion in the POLITICO article, "As Trump raises tariffs, companies find ways to cheat — and risk getting caught."
July 23, 2025
In the News
Aaron Maguregui on AI Scribes in Health Care – 'Technically, it's a third party listening'
Foley & Lardner LLP partner Aaron Maguregui shared insights on the growing applications for artificial intelligence across health care in the healthleaders article, “Is Your AI Scribe HIPAA-Compliant?“